| Product Code: ETC8287278 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market - Industry Life Cycle |
3.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market - Porter's Five Forces |
3.5 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Product and Services, 2021 & 2031F |
3.8 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.10 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of preimplantation genetic screening (PGS) technology in Mexico |
4.2.2 Growing demand for advanced fertility treatments and procedures |
4.2.3 Rising prevalence of genetic disorders and chromosomal abnormalities in embryos |
4.3 Market Restraints |
4.3.1 High cost associated with PGS technology and procedures |
4.3.2 Limited access to specialized healthcare facilities offering PGS services in Mexico |
4.3.3 Ethical and legal considerations surrounding the use of genetic screening technologies |
5 Mexico Preimplantation Genetic Screening (PGS) Technology Market Trends |
6 Mexico Preimplantation Genetic Screening (PGS) Technology Market, By Types |
6.1 Mexico Preimplantation Genetic Screening (PGS) Technology Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Screening, 2021- 2031F |
6.1.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Preimplantation Genetic Diagnosis, 2021- 2031F |
6.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Polymerase Chain Reaction, 2021- 2031F |
6.2.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fluorescence in Situ Hybridization, 2021- 2031F |
6.2.5 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Comparative Genomic Hybridization, 2021- 2031F |
6.2.6 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Single-Nucleotide Polymorphism, 2021- 2031F |
6.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market, By Product and Services |
6.3.1 Overview and Analysis |
6.3.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Reagents and Consumables, 2021- 2031F |
6.3.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Software and Services, 2021- 2031F |
6.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Maternity Centers, 2021- 2031F |
6.4.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Fertility Clinics, 2021- 2031F |
6.4.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Hospitals, Diagnostic Labs, 2021- 2031F |
6.4.5 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Service Providers, 2021- 2031F |
6.4.6 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.7 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
6.5 Mexico Preimplantation Genetic Screening (PGS) Technology Market, By Test Type |
6.5.1 Overview and Analysis |
6.5.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Chromosomal Abnormalities, 2021- 2031F |
6.5.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By X-linked Diseases, Embryo Testing, 2021- 2031F |
6.5.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Aneuploidy Screening, 2021- 2031F |
6.5.5 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By HLA Typing, 2021- 2031F |
6.5.6 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Other, 2021- 2031F |
6.6 Mexico Preimplantation Genetic Screening (PGS) Technology Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Embryo HLA Typing for Stem Cell Therapy, 2021- 2031F |
6.6.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By IVF Prognosis, 2021- 2031F |
6.6.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Late Onset Genetic Disorders, 2021- 2031F |
6.6.5 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Inherited Genetic Disease, 2021- 2031F |
6.6.6 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Preimplantation Genetic Screening (PGS) Technology Market Import-Export Trade Statistics |
7.1 Mexico Preimplantation Genetic Screening (PGS) Technology Market Export to Major Countries |
7.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Imports from Major Countries |
8 Mexico Preimplantation Genetic Screening (PGS) Technology Market Key Performance Indicators |
8.1 Number of fertility clinics offering PGS services in Mexico |
8.2 Adoption rate of PGS technology among fertility specialists in the country |
8.3 Number of successful pregnancies resulting from PGS procedures |
8.4 Average waiting time for patients seeking PGS services |
8.5 Rate of genetic abnormalities detected and prevented through PGS screenings |
9 Mexico Preimplantation Genetic Screening (PGS) Technology Market - Opportunity Assessment |
9.1 Mexico Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Mexico Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Product and Services, 2021 & 2031F |
9.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Mexico Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.6 Mexico Preimplantation Genetic Screening (PGS) Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Mexico Preimplantation Genetic Screening (PGS) Technology Market - Competitive Landscape |
10.1 Mexico Preimplantation Genetic Screening (PGS) Technology Market Revenue Share, By Companies, 2024 |
10.2 Mexico Preimplantation Genetic Screening (PGS) Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here